FSF. Sartori

F. Sartori

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


F. Sartori has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Long-Term Results of Surgical Management of Pulmonary Metastases from Renal Cell Carcinoma

    by G. Marulli, F. Sartori, P. F. Bassi, F. Dal Moro, A. Gino Favaretto, F. Rea

    Background: Metastatic renal cell carcinoma (RCC) has a poor prognosis and conventional treatments such as chemoradiotherapy show little efficacy. Surgical resection of pulmonary metastases from RCC is a widely accepted treatment, even if selection criteria based on prognostic factors have still not been defined. The aim of this study was to determine the long-term survival, clinical outcome and prognostic factors after surgery. Methods: Between 1988 and 2004, 59 patients underwent resection of pulmonary metastases from RCC. Univariate and multivariate analysis of prognostic factors was carried out. Results: Complete resection was achieved in 54 (91.5 %) patients. No intra- or postoperative mortality occurred, 5 (8.5 %) patients experienced postoperative complications. Overall, the 1-, 3-, and 5-year survival rates were 86.5 %, 63 % and 53 %, respectively. Age at the time of pulmonary resection was found to be the only independent factor influencing prognosis. Conclusion: Pulmonary resection of metastases from RCC is a safe and effective treatment associated with a low morbidity and mortality and with high long-term survival. The lack of other effective therapies suggests use of the surgical approach whenever possible.


  • Open Access

    The surgeon and the oncologist in non-small cell lung cancer (NSCLC)

    by F. Sartori, L. Bortolotti, G. Marulli, G. Rizzardi, A. Favaretto, A. Zuin, C. Breda, F. Rea

    A strict collaboration is necessary between the oncologist and the surgeon, both must know the respective problematic and competences and must contribute together to all phases of clinical management of patients affected by NSCLC.


    • 1 January 1995
      • Vol. 47  (5) , 40-2

    [Indications for and results of video-assisted thoracic surgery].

    by C Breda, F Calabrò, F Rea, F Sartori

    Between January 1991 and February 1996, and February 1996, 222 videothoracoscopic operations were conducted in 215 patients. Indications for video-assisted thoracic surgery (Vats) have included management of pneumothorax, (91), pleural effusion (59), lung nodules (41), mediastinal biopsy (8), need for lung biopsy (10), small endothoracic masses (6), haemothorax (4), gangliectomy in Raynaud syndrome (1), the removal of jugular vein catheter (1), and middle lobectomy for A-V fistula (1). Fifteen procedures were converted to thoracotomy; nine conversions were made for more extensive resection after a diagnosis of primary lung malignancy. Other reasons for conversion were adhesions (6). There was one complication (haemothorax). There were no intraoperative deaths. Mean operative time was 60 min. (median line); the median chest tube duration was three days and hospital stay five days. The video-assisted thoracic surgery procedures were safe, and for patients the advantages included less pain and earlier post-operative mobilization.

    • 1 January 1995
      • Vol. 47  (3) , 24-6

    [Carcinoma of the lung involving the thoracic wall].

    by F Sartori, C Breda, F Rea

    Carcinoma of the lung involving the chest wall causes severe pain. An unusual type of chest wall tumour is Pancoast's carcinoma, also called "the superior sulcus tumour". The long tumour involving the chest wall is considered a T3 lesion and hence stage IIIa. Reconstruction of the chest wall is generally achieved with autogenous tissue; The treatment of a superior sulcus tumour consists of preoperative radiotherapy followed by radical surgical resection of the lung, involving chest wall nerve endings. In Pancoast's tumour 5-year survival is reported as between 23% and 40% with combined irradiation and operation for T3-NO lesions.

    • 1 September 1992
      • Vol. 104  (3) , 679-83

    Carcinoma of the superior pulmonary sulcus. Results of irradiation and radical resection.

    by F Sartori, F Rea, F Calabrò, C Mazzucco, L Bortolotti, L Tomio

    Fifty-six patients with superior sulcus syndrome were evaluated at the First Surgical Department of the University of Padua between 1981 and 1990. Forty-two patients with the characteristic of Pancoast's tumor received preoperative irradiation and then en bloc resection of the tumor, chest wall, and adjacent structures. Seven lobectomies and 35 segmentectomies or wedge resections were performed. There was one early postoperative death. Median survival was 14 months, and actuarial survival was 25% at 5 years. Patients with pain relief had better 5-year survival (36.4%) than patients without pain relief (9%). We have no patients with vertebral invasion who survived more than 1 year. Of the five patients with subclavian artery invasion, only one survived more than 1 year. Of five patients with N2 disease, only one survived more than 1 year. Our results suggest that pain relief after irradiation is a good prognostic factor, whereas N2 involvement and vertebral body and great vessel invasion are ominous factors. Another ominous prognostic factor is the Claude Bernard-Horner syndrome even if it is not a contraindication to resection.


    • 1 January 1990
      • p. 125-7

    [Pancoast's tumor].

    by F Sartori, F Rea, F Calabrò

    • 15 February 1989
      • Vol. 44  (3) , 361-4

    [Sleeve resection: possibilities and risks].

    by F Sartori, F Rea, F Calabrò, R Binda

    • 31 March 1988
      • Vol. 43  (6) , 515-8

    [Comparison of resorbable and non-resorbable monofilaments in tracheal sutures. Experimental study in rats].

    by F Rea, F Calabrò, A Busetto, A Fassina, F Sartori

    • 15 March 1988
      • Vol. 43  (5) , 441-3

    [Resection and reconstruction of the carina by median sternotomy approach].

    by F Rea, F Calabrò, R Binda, S Ardit, M Vigo, F Sartori

    • 1 October 1986
      • Vol. 71  (4) , 233-6

    Sleeve lobectomy in the treatment of bronchogenic carcinoma.

    by F Sartori, R Binda, G Spreafico, F Calabrò, F Rea, R Nistri, F Cicinnati, A Cipriani, G Di Vittorio, C Polico

    From 1980 to 1985, 44 sleeve lobectomies were carried out in patients with bronchial cancer. Sixteen patients received preoperative radiotherapy. Perioperative mortality was 6.8%. There were seven anastomotic complications (three fistulae and four stenoses) and two recurrences at the anastomosis. Overall actuarial survival was 45% at four years. These results seem to suggest that sleeve lobectomy should be considered an elective rather than a compromise procedure and a viable alternative to pneumonectomy. Preoperative radiotherapy neither increases complications nor has a negative effect on outcome. It contributes towards reducing local recurrences and maximizes tissue salvage. Long-term survival is related to stage or histology, factors generally governing the survival of lung cancer operated patients, although the TNM classification is ill-suited to identifying tumors which can be resected by a sleeve lobectomy.